Bacterial efflux pump modulators prevent bacterial growth in macrophages and under broth conditions that mimic the host environment

ABSTRACTNew approaches for combating microbial infections are needed. One strategy for disrupting pathogenesis involves developing compounds that interfere with bacterial virulence. A critical molecular determinant of virulence for Gram-negative bacteria are efflux pumps of the resistance-nodulation...

Full description

Bibliographic Details
Main Authors: Samual C. Allgood, Chih-Chia Su, Amy L. Crooks, Christian T. Meyer, Bojun Zhou, Meredith D. Betterton, Michael R. Barbachyn, Edward W. Yu, Corrella S. Detweiler
Format: Article
Language:English
Published: American Society for Microbiology 2023-12-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mbio.02492-23
_version_ 1797378906829881344
author Samual C. Allgood
Chih-Chia Su
Amy L. Crooks
Christian T. Meyer
Bojun Zhou
Meredith D. Betterton
Michael R. Barbachyn
Edward W. Yu
Corrella S. Detweiler
author_facet Samual C. Allgood
Chih-Chia Su
Amy L. Crooks
Christian T. Meyer
Bojun Zhou
Meredith D. Betterton
Michael R. Barbachyn
Edward W. Yu
Corrella S. Detweiler
author_sort Samual C. Allgood
collection DOAJ
description ABSTRACTNew approaches for combating microbial infections are needed. One strategy for disrupting pathogenesis involves developing compounds that interfere with bacterial virulence. A critical molecular determinant of virulence for Gram-negative bacteria are efflux pumps of the resistance-nodulation-division family, which includes AcrAB-TolC. We previously identified small molecules that bind AcrB, inhibit AcrAB-TolC, and do not appear to damage membranes. These efflux pump modulators (EPMs) were discovered in an in-cell screening platform called SAFIRE (Screen for Anti-infectives using Fluorescence microscopy of IntracellulaR Enterobacteriaceae). SAFIRE identifies compounds that disrupt the growth of a Gram-negative human pathogen, Salmonella enterica serotype Typhimurium (S. Typhimurium), in macrophages. We used medicinal chemistry to iteratively design ~200 EPM35 analogs and test them for activity in SAFIRE, generating compounds with nanomolar potency. Analogs were demonstrated to bind AcrB in a substrate binding pocket by cryo-electron microscopy. Despite having amphipathic structures, the EPM analogs do not disrupt membrane voltage, as monitored by FtsZ localization to the cell septum. The EPM analogs had little effect on bacterial growth in standard Mueller Hinton Broth. However, under broth conditions that mimic the micro-environment of the macrophage phagosome, acrAB is required for growth, the EPM analogs are bacteriostatic, and the EPM analogs increase the potency of antibiotics. These data suggest that under macrophage-like conditions, the EPM analogs prevent the export of a toxic bacterial metabolite(s) through AcrAB-TolC. Thus, compounds that bind AcrB could disrupt infection by specifically interfering with the export of bacterial toxic metabolites, host defense factors, and/or antibiotics.IMPORTANCEBacterial efflux pumps are critical for resistance to antibiotics and for virulence. We previously identified small molecules that inhibit efflux pumps (efflux pump modulators, EPMs) and prevent pathogen replication in host cells. Here, we used medicinal chemistry to increase the activity of the EPMs against pathogens in cells into the nanomolar range. We show by cryo-electron microscopy that these EPMs bind an efflux pump subunit. In broth culture, the EPMs increase the potency (activity), but not the efficacy (maximum effect), of antibiotics. We also found that bacterial exposure to the EPMs appear to enable the accumulation of a toxic metabolite that would otherwise be exported by efflux pumps. Thus, inhibitors of bacterial efflux pumps could interfere with infection not only by potentiating antibiotics, but also by allowing toxic waste products to accumulate within bacteria, providing an explanation for why efflux pumps are needed for virulence in the absence of antibiotics.
first_indexed 2024-03-08T20:14:23Z
format Article
id doaj.art-c39352faf2c44a41aedbedba1f9e7998
institution Directory Open Access Journal
issn 2150-7511
language English
last_indexed 2024-03-08T20:14:23Z
publishDate 2023-12-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj.art-c39352faf2c44a41aedbedba1f9e79982023-12-22T19:53:44ZengAmerican Society for MicrobiologymBio2150-75112023-12-0114610.1128/mbio.02492-23Bacterial efflux pump modulators prevent bacterial growth in macrophages and under broth conditions that mimic the host environmentSamual C. Allgood0Chih-Chia Su1Amy L. Crooks2Christian T. Meyer3Bojun Zhou4Meredith D. Betterton5Michael R. Barbachyn6Edward W. Yu7Corrella S. Detweiler8Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, USADepartment of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USAMolecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, USAMolecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, USADepartment of Physics, University of Colorado, Boulder, Colorado, USAMolecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, USABarbachyn Consulting, LLC, Kalamazoo, Michigan, USADepartment of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USAMolecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, USAABSTRACTNew approaches for combating microbial infections are needed. One strategy for disrupting pathogenesis involves developing compounds that interfere with bacterial virulence. A critical molecular determinant of virulence for Gram-negative bacteria are efflux pumps of the resistance-nodulation-division family, which includes AcrAB-TolC. We previously identified small molecules that bind AcrB, inhibit AcrAB-TolC, and do not appear to damage membranes. These efflux pump modulators (EPMs) were discovered in an in-cell screening platform called SAFIRE (Screen for Anti-infectives using Fluorescence microscopy of IntracellulaR Enterobacteriaceae). SAFIRE identifies compounds that disrupt the growth of a Gram-negative human pathogen, Salmonella enterica serotype Typhimurium (S. Typhimurium), in macrophages. We used medicinal chemistry to iteratively design ~200 EPM35 analogs and test them for activity in SAFIRE, generating compounds with nanomolar potency. Analogs were demonstrated to bind AcrB in a substrate binding pocket by cryo-electron microscopy. Despite having amphipathic structures, the EPM analogs do not disrupt membrane voltage, as monitored by FtsZ localization to the cell septum. The EPM analogs had little effect on bacterial growth in standard Mueller Hinton Broth. However, under broth conditions that mimic the micro-environment of the macrophage phagosome, acrAB is required for growth, the EPM analogs are bacteriostatic, and the EPM analogs increase the potency of antibiotics. These data suggest that under macrophage-like conditions, the EPM analogs prevent the export of a toxic bacterial metabolite(s) through AcrAB-TolC. Thus, compounds that bind AcrB could disrupt infection by specifically interfering with the export of bacterial toxic metabolites, host defense factors, and/or antibiotics.IMPORTANCEBacterial efflux pumps are critical for resistance to antibiotics and for virulence. We previously identified small molecules that inhibit efflux pumps (efflux pump modulators, EPMs) and prevent pathogen replication in host cells. Here, we used medicinal chemistry to increase the activity of the EPMs against pathogens in cells into the nanomolar range. We show by cryo-electron microscopy that these EPMs bind an efflux pump subunit. In broth culture, the EPMs increase the potency (activity), but not the efficacy (maximum effect), of antibiotics. We also found that bacterial exposure to the EPMs appear to enable the accumulation of a toxic metabolite that would otherwise be exported by efflux pumps. Thus, inhibitors of bacterial efflux pumps could interfere with infection not only by potentiating antibiotics, but also by allowing toxic waste products to accumulate within bacteria, providing an explanation for why efflux pumps are needed for virulence in the absence of antibiotics.https://journals.asm.org/doi/10.1128/mbio.02492-23AcrAB-TolCcryo-electron microscopyGram-negative bacteriaefflux pumpmacrophageSAFIRE
spellingShingle Samual C. Allgood
Chih-Chia Su
Amy L. Crooks
Christian T. Meyer
Bojun Zhou
Meredith D. Betterton
Michael R. Barbachyn
Edward W. Yu
Corrella S. Detweiler
Bacterial efflux pump modulators prevent bacterial growth in macrophages and under broth conditions that mimic the host environment
mBio
AcrAB-TolC
cryo-electron microscopy
Gram-negative bacteria
efflux pump
macrophage
SAFIRE
title Bacterial efflux pump modulators prevent bacterial growth in macrophages and under broth conditions that mimic the host environment
title_full Bacterial efflux pump modulators prevent bacterial growth in macrophages and under broth conditions that mimic the host environment
title_fullStr Bacterial efflux pump modulators prevent bacterial growth in macrophages and under broth conditions that mimic the host environment
title_full_unstemmed Bacterial efflux pump modulators prevent bacterial growth in macrophages and under broth conditions that mimic the host environment
title_short Bacterial efflux pump modulators prevent bacterial growth in macrophages and under broth conditions that mimic the host environment
title_sort bacterial efflux pump modulators prevent bacterial growth in macrophages and under broth conditions that mimic the host environment
topic AcrAB-TolC
cryo-electron microscopy
Gram-negative bacteria
efflux pump
macrophage
SAFIRE
url https://journals.asm.org/doi/10.1128/mbio.02492-23
work_keys_str_mv AT samualcallgood bacterialeffluxpumpmodulatorspreventbacterialgrowthinmacrophagesandunderbrothconditionsthatmimicthehostenvironment
AT chihchiasu bacterialeffluxpumpmodulatorspreventbacterialgrowthinmacrophagesandunderbrothconditionsthatmimicthehostenvironment
AT amylcrooks bacterialeffluxpumpmodulatorspreventbacterialgrowthinmacrophagesandunderbrothconditionsthatmimicthehostenvironment
AT christiantmeyer bacterialeffluxpumpmodulatorspreventbacterialgrowthinmacrophagesandunderbrothconditionsthatmimicthehostenvironment
AT bojunzhou bacterialeffluxpumpmodulatorspreventbacterialgrowthinmacrophagesandunderbrothconditionsthatmimicthehostenvironment
AT meredithdbetterton bacterialeffluxpumpmodulatorspreventbacterialgrowthinmacrophagesandunderbrothconditionsthatmimicthehostenvironment
AT michaelrbarbachyn bacterialeffluxpumpmodulatorspreventbacterialgrowthinmacrophagesandunderbrothconditionsthatmimicthehostenvironment
AT edwardwyu bacterialeffluxpumpmodulatorspreventbacterialgrowthinmacrophagesandunderbrothconditionsthatmimicthehostenvironment
AT correllasdetweiler bacterialeffluxpumpmodulatorspreventbacterialgrowthinmacrophagesandunderbrothconditionsthatmimicthehostenvironment